Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Summit Therapeutics Inc. (SMMT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023"
08/02/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics to Host Q2 2023 Financial Results"
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Phase III Study with Additional Phase III Study Planned for Third Quarter 2023 for Ivonescimab Menlo Park, California, June 1, 2023"
05/25/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab"
05/03/2023 8-K Quarterly results
04/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
03/17/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/13/2023 SC 13D/A Zanganeh Mahkam reports a 5.3% stake in Summit Therapeutics Inc.
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022 Earnings Call with Management Team Scheduled for Today"
02/23/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics’ Rights Offering Nearing Expiration Date"
02/14/2023 SC 13G/A Polar Capital Holdings Plc reports a 0% stake in Summit Therapeutics Inc.
02/07/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
01/30/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Therapeutics Announces Timing of Rights Offering for Up to"
01/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
01/20/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
01/09/2023 8-K Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure,...
Docs: "J.P. Morgan 41st Annual Healthcare Conference 2023 Bob Duggan Dr. Maky Zanganeh Chairman"
12/27/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/21/2022 8-K Quarterly results
12/21/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
12/21/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
12/13/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/09/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/06/2022 8-K Quarterly results
11/29/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
11/17/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy